Trigger Finger
Conditions
Keywords
Trigger Finger, A1 Pulley Release, Ultrasound-Guided Technique
Brief summary
Efficacy of ultrasound-guided tri-directional needle knife release in treating patients with trigger finger. The study evaluates safety, effectiveness, and recovery outcomes of a minimally invasive procedure compared to conventional approaches.
Detailed description
This is a clinical trial designed to investigate the efficacy and safety of ultrasound-guided tri-directional needle knife release in patients with trigger finger, especially those patients for whom conservative treatments have failed. Trigger finger is caused by of thickening of the A1 pulley, leading to pain and stiffness, which results in limitation of the hand. The procedure will be carried out under local anesthesia and guided by ultrasound to be very accurate and safe, avoiding all possible risks. Patients will be assessed for better improvement in hand functioning, pain scale basing on visual analog scale, and above all patient overall satisfaction.
Interventions
PROCEDURETri-directional Ultrasound-guided Needle Knife Release
This procedure involves ultrasound-guided tri-directional needle knife release for the treatment of trigger finger. Local anesthesia using 3-5 ml of 1% lidocaine and 0.25% bupivacaine will be administered for patient comfort. It aims to ensure precise tissue dissection while minimizing risks and improving outcomes. Device: Sonosite M-Turbo Ultrasound Machine with Linear Probe HFL38x (6-13 MHz) is used for real-time imaging during the procedure.
Sponsors
Mohamed Maher Ismail Ahmed Elashmawy
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
All participants will undergo ultrasound-guided tri-directional needle knife release for trigger finger treatment
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Idiopathic TF at the level of A1 pulley * Trigger finger of Green's grades II or III or IV (moderate to severe) * Symptoms persist for at least three months despite conservative treatments. * Ability to provide informed consent and comply with follow-up requirements.
Exclusion criteria
* Patients with secondary causes of TF like diabetes mellitus, rheumatoid arthritis, gout, hypothyroidism, amyloidosis, and sarcoidosis. * Patients with TF of Green's grade I. * Previous surgical intervention on the affected digit. * Allergy or contraindication to local anesthetics. * Pregnancy or lactation. * Inability to comply with follow-up assessments.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in hand and finger function | 6 months | Functional improvement evaluation using the QuickDASH score (0-100 scale) |
| Reduction in Pain scores post-procedure | 6 months | Evaluating of the effectiveness of ultrasound-guided tri-directional needle knife release in reducing pain scores among patients with trigger finger using the Visual Analog Scale (VAS) (scale 0-10) |
| Improvement of finger mobility | 6 months | Measurment of joint mobility in degrees at MCP and PIP joints using goniometer. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient Satisfaction with the procedure | 6 months | Evaluating of patient satisfaction levels using a structured questionnaire |
| Rate of procedure-related complications | 6 months | Monitoring and documentation of procedure-related complications, including infection, nerve injury, and other adverse events. |
Countries
Egypt
Outcome results
None listed